Free Trial

Assembly Biosciences (ASMB) Short Interest Ratio & Short Volume

Assembly Biosciences logo
$15.21 -0.60 (-3.80%)
(As of 12/20/2024 05:15 PM ET)

Assembly Biosciences Short Interest Data

Assembly Biosciences (ASMB) has a short interest of 15,900 shares, representing 0.36% of the float (the number of shares available for trading by the public). This marks a 37.07% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 25,218 shares to cover all short positions.

Current Short Interest
15,900 shares
Previous Short Interest
11,600 shares
Change Vs. Previous Month
+37.07%
Dollar Volume Sold Short
$270,936.00
Short Interest Ratio
0.5 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
6,356,000 shares
Float Size
4,470,000 shares
Short Percent of Float
0.36%
Today's Trading Volume
30,654 shares
Average Trading Volume
25,218 shares
Today's Volume Vs. Average
122%
Short Selling Assembly Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Assembly Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ASMB Short Interest Over Time

ASMB Days to Cover Over Time

ASMB Percentage of Float Shorted Over Time

Assembly Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/202415,900 shares $270,936.00 +37.1%0.4%0.5 $17.04
11/15/202411,600 shares $187,224.00 +45.0%0.3%0.4 $16.14
10/31/20248,000 shares $134,480.00 -51.2%0.2%0.3 $16.81
10/15/202416,400 shares $303,728.00 -7.9%0.4%0.6 $18.52
9/30/202417,800 shares $269,492.00 -22.9%0.4%0.8 $15.14
9/15/202423,100 shares $417,417.00 +42.6%0.5%1.1 $18.07
8/31/202416,200 shares $263,412.00 +57.3%0.4%1 $16.26
8/15/202410,300 shares $144,715.00 -16.3%0.2%0.7 $14.05
7/31/202412,300 shares $179,641.50 -14.6%0.3%0.8 $14.61
7/15/202414,400 shares $221,328.00 -23.8%0.3%0.9 $15.37
6/30/202418,900 shares $259,308.00 +17.4%0.5%1.1 $13.72
6/15/202416,100 shares $247,779.00 -12.0%0.4%0.9 $15.39
5/31/202418,300 shares $277,245.00 -14.1%0.5%1 $15.15
5/15/202421,300 shares $311,193.00 -14.1%0.6%1.1 $14.61
4/30/202424,800 shares $309,256.00 -19.0%0.7%1 $12.47
4/15/202430,600 shares $456,858.00 -28.2%0.8%1.1 $14.93
3/31/202442,600 shares $566,580.00 -29.2%1.2%1.4 $13.30
3/15/202460,200 shares $732,634.00 +207.1%1.6%2 $12.17
2/29/202419,600 shares $250,684.00 -63.0%0.5%0.6 $12.79
2/15/202453,000 shares $620,100.00 -85.0%1.4%1.6 $11.70
1/31/2024353,300 shares $3.99 million -22.1%N/A0.7 $11.28
1/15/2024453,600 shares $367,416.00 +125.7%N/A0.7 $0.81
12/31/2023201,000 shares $164,840.10 -20.7%N/A0.1 $0.82
12/15/2023253,600 shares $190,935.44 -52.0%N/A0.1 $0.75
11/30/2023528,000 shares $369,652.80 -18.7%2.3%0.3 $0.70
11/15/2023649,700 shares $479,478.60 -17.3%2.8%0.3 $0.74
10/31/2023785,300 shares $688,629.57 +469.1%4.1%0.5 $0.88
10/15/2023138,000 shares $98,118.00 +2.7%N/A0.1 $0.71
9/30/2023134,400 shares $118,944.00 -6.5%N/A1.2 $0.89
9/15/2023143,800 shares $130,814.86 +14.6%N/A1.5 $0.91
8/31/2023125,500 shares $124,232.45 -20.8%N/A1.4 $0.99
8/15/2023158,400 shares $156,736.80 -14.8%N/A1.6 $0.99
7/31/2023185,900 shares $206,349.00 +13.0%N/A1.8 $1.11
7/15/2023164,500 shares $177,660.00 +0.7%N/A1.5 $1.08
6/30/2023163,300 shares $187,795.00 -44.8%N/A1.1 $1.15
6/15/2023295,700 shares $319,356.00 +2.7%N/A1.7 $1.08
5/31/2023287,900 shares $275,750.62 +78.5%N/A1.4 $0.96
5/15/2023161,300 shares $167,752.00 -5.5%N/A0.8 $1.04
4/30/2023170,600 shares $177,424.00 -43.6%N/A0.8 $1.04
4/15/2023302,700 shares $299,673.00 +84.5%N/A1.2 $0.99
Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry. 
3/31/2023164,100 shares $137,909.64 +26.7%N/A0.7 $0.84
3/15/2023129,500 shares $170,940.00 -14.0%N/A0.5 $1.32
2/28/2023150,600 shares $204,816.00 -0.4%N/A0.5 $1.36
2/15/2023151,200 shares $231,336.00 -1.3%N/A0.5 $1.53
1/31/2023153,200 shares $266,568.00 -52.8%N/A0.5 $1.74
1/15/2023324,500 shares $499,730.00 +49.0%N/A1.1 $1.54
12/30/2022217,800 shares $283,140.00 +15.5%N/A0.7 $1.30
12/15/2022188,500 shares $218,660.00 -82.2%N/A0.7 $1.16
11/30/20221,060,000 shares $1.39 million -16.5%N/A4.6 $1.31
11/15/20221,270,000 shares $1.77 million -9.9%N/A5.6 $1.39
10/31/20221,410,000 shares $2.31 million -5.4%N/A6.2 $1.64
10/15/20221,490,000 shares $2.47 million +6.4%N/A6.3 $1.66
9/30/20221,400,000 shares $2.30 million +2.9%N/A4.7 $1.64
9/15/20221,360,000 shares $2.84 million -3.6%N/A4.2 $2.09
8/31/20221,410,000 shares $2.64 million +10.2%N/A3.3 $1.87
8/15/20221,280,000 shares $2.75 million +1.6%N/A2.8 $2.15
7/31/20221,260,000 shares $2.61 million -2.3%N/A2.6 $2.07
7/15/20221,290,000 shares $2.63 million +42.8%5.8%2.6 $2.04
6/30/2022903,300 shares $1.90 million -17.9%4.0%1.9 $2.10
6/15/20221,100,000 shares $2.08 million -3.5%4.9%2.2 $1.89
5/31/20221,140,000 shares $2.18 million -14.3%N/A2.5 $1.91
5/15/20221,330,000 shares $2.05 million -7.6%N/A3 $1.54
4/30/20221,440,000 shares $2.53 million No ChangeN/A3.1 $1.76
4/15/20221,440,000 shares $2.98 million -0.7%N/A3 $2.07
3/31/20221,450,000 shares $2.99 million +16.9%N/A2.7 $2.06
3/15/20221,240,000 shares $1.84 million +4.2%N/A2.1 $1.48
2/28/20221,190,000 shares $1.84 million +2.6%N/A2 $1.55
2/15/20221,160,000 shares $1.88 million -13.4%N/A1.6 $1.62
1/31/20221,340,000 shares $2.49 million +8.9%N/A1.5 $1.86
1/15/20221,230,000 shares $2.40 million +7.9%N/A1.4 $1.95
12/31/20211,140,000 shares $2.66 million -13.0%N/A1.4 $2.33
12/15/20211,310,000 shares $2.84 million -15.5%N/A1.6 $2.17
11/30/20211,550,000 shares $3.57 million +21.1%N/A2 $2.30
11/15/20211,280,000 shares $3.60 million -8.6%N/A1.5 $2.81
10/29/20211,400,000 shares $4.41 million +23.9%N/A2.1 $3.15
10/15/20211,130,000 shares $3.68 million -22.1%N/A1.5 $3.26
9/30/20211,450,000 shares $5.05 million -8.2%N/A1.8 $3.48
9/15/20211,580,000 shares $5.06 million -1.9%N/A1.5 $3.20
8/31/20211,610,000 shares $6.12 million -42.1%N/A1.3 $3.80
8/13/20212,780,000 shares $9.95 million -3.5%N/A2.3 $3.58
7/30/20212,880,000 shares $9.99 million -31.4%7.9%2.4 $3.47
7/15/20214,200,000 shares $14.41 million -12.1%11.5%3.5 $3.43
6/30/20214,780,000 shares $18.55 million -6.5%13.0%4.1 $3.88
6/15/20215,110,000 shares $21.05 million +8.7%13.9%5.4 $4.12
5/28/20214,700,000 shares $18.66 million +5.2%12.8%5.5 $3.97
5/14/20214,470,000 shares $17.39 million -8.0%N/A4.3 $3.89
4/30/20214,860,000 shares $20.85 million +20.6%N/A3.9 $4.29
4/15/20214,030,000 shares $17.85 million -4.7%N/A3.1 $4.43
3/31/20214,230,000 shares $19.04 million +15.3%N/A3.3 $4.50
3/15/20213,670,000 shares $18.86 million -5.2%N/A2.8 $5.14
Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry. 
2/26/20213,870,000 shares $21.40 million +55.4%N/A3 $5.53
2/12/20212,490,000 shares $15.86 million +4.6%N/A2.2 $6.37
1/29/20212,380,000 shares $13.26 million -8.5%N/A1.5 $5.57
1/15/20212,600,000 shares $16.17 million -4.8%N/A1.9 $6.22
12/31/20202,730,000 shares $16.60 million -8.7%N/A2.2 $6.08
12/15/20202,990,000 shares $18.60 million No ChangeN/A2.5 $6.22
11/30/20202,990,000 shares $17.94 million +4.2%N/A2.7 $6.00
11/15/20202,870,000 shares $16.13 million -30.2%N/A3 $5.62
10/30/20204,110,000 shares $61.61 million +5.4%N/A5.7 $14.99
10/15/20203,900,000 shares $60.22 million +1.3%N/A16.5 $15.44
9/30/20203,850,000 shares $63.29 million +4.3%N/A16.6 $16.44
9/15/20203,690,000 shares $65.57 million -1.1%N/A15.7 $17.77
8/31/20203,730,000 shares $81.58 million +0.3%N/A17.3 $21.87
8/14/20203,720,000 shares $77.97 million -1.1%N/A17.1 $20.96
7/31/20203,760,000 shares $83.47 million -2.3%N/A16.8 $22.20
7/15/20203,850,000 shares $90.86 million +5.8%N/A18.1 $23.60
6/30/20203,640,000 shares $84.88 million +16.7%N/A17.5 $23.32
6/15/20203,120,000 shares $66.39 million +0.3%N/A14.2 $21.28
5/29/20203,110,000 shares $60.96 million No ChangeN/A13.1 $19.60
5/15/20203,110,000 shares $57.72 million +1.0%N/A12.8 $18.56
4/30/20203,080,000 shares $53.93 million +11.2%N/A12.1 $17.51
4/15/20202,770,000 shares $46.92 million +12.6%N/A10.3 $16.94
3/31/20202,460,000 shares $44.77 million +9.7%N/A8.4 $18.20
3/13/20202,241,900 shares $36.81 million -1.2%N/A9.9 $16.42
2/28/20202,270,000 shares $33.28 million -0.4%N/A5.4 $14.66
2/14/20202,280,000 shares $37.98 million -0.9%9.7%5.2 $16.66
1/31/20202,300,000 shares $45.75 million -0.4%9.8%4.3 $19.89
1/15/20202,310,000 shares $47.22 million +8.5%9.8%3.9 $20.44
12/31/20192,130,000 shares $35.59 million -18.7%9.3%2.8 $16.71

ASMB Short Interest - Frequently Asked Questions

What is Assembly Biosciences' current short interest?

Short interest is the volume of Assembly Biosciences shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 15,900 shares of ASMB short. 0.36% of Assembly Biosciences' shares are currently sold short. Learn More on Assembly Biosciences' current short interest.

What is a good short interest percentage for Assembly Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of Assembly Biosciences' floating shares are currently sold short.

Is Assembly Biosciences' short interest increasing or decreasing?

Assembly Biosciences saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 15,900 shares, an increase of 37.1% from the previous total of 11,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Assembly Biosciences' float size?

Assembly Biosciences currently has issued a total of 6,356,000 shares. Some of Assembly Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Assembly Biosciences currently has a public float of 4,470,000 shares.

How does Assembly Biosciences' short interest compare to its competitors?

0.36% of Assembly Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Assembly Biosciences: Nektar Therapeutics (2.49%), Cumberland Pharmaceuticals Inc. (2.09%), Eli Lilly and Company (0.69%), Johnson & Johnson (0.77%), AbbVie Inc. (1.09%), Merck & Co., Inc. (1.30%), Pfizer Inc. (1.59%), Bristol-Myers Squibb (1.26%), Zoetis Inc. (1.22%), Royalty Pharma plc (4.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Assembly Biosciences stock?

Short selling ASMB is an investing strategy that aims to generate trading profit from Assembly Biosciences as its price is falling. ASMB shares are trading down $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Assembly Biosciences?

A short squeeze for Assembly Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASMB, which in turn drives the price of the stock up even further.

How often is Assembly Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASMB, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:ASMB) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners